Cancer Biology

Discussions of New Developments and Updates

Home
About
Topics
SHU Department of Biology

Tag Archives: Regen Biopharma

IND for Clinical Studies of dCellVax Breast Cancer Immune Therapy Filed – Intelligent and Rational Gene Silencing Approach for Cancer

Regen Biopharma recently filed an IND (Investigational New Drug Application) with the FDA to permit the initiation of Phase 1 clinical trials of its dCellVax treatment for advanced breast cancer. Continue reading →

This entry was posted in Checkpoint Inhibitors, IDO, Uncategorized, Vaccines and tagged breast cancer, checkpoint, cytotoxic T-cells, IDO, Regen Biopharma, siRNA, Treg, vaccine on October 19, 2014 by Joseph Gulfo.

Search for:

This blog is designed to provide updates in developments in cancer biology and engage in discussions about new findings in the field.

Sponsored by the Department of Biology, Seton Hall University.

@josephgulfo

[fts_twitter twitter_name=@josephgulfo tweets_count=6 cover_photo=no stats_bar=no show_retweets=no show_replies=no]

Proudly powered by WordPress

Pin It on Pinterest